Hormone-refractory prostate cancer: a multi-step and multi-event process.
about
Efficacy of carboplatin-taxane combinations in the management of castration-resistant prostate cancer: a pooled analysis of seven prospective clinical trialsAndrogen depletion induces senescence in prostate cancer cells through down-regulation of Skp2Application of Affymetrix array and Massively Parallel Signature Sequencing for identification of genes involved in prostate cancer progressionNuclear factor-kappaB/p65 (Rel A) is constitutively activated in human prostate adenocarcinoma and correlates with disease progressionRestoration of PTEN expression alters the sensitivity of prostate cancer cells to EGFR inhibitors.Differential expression of IL-17RC isoforms in androgen-dependent and androgen-independent prostate cancersThe androgen receptor and mechanisms for androgen independence in prostate cancer.A SOCS-1 peptide mimetic inhibits both constitutive and IL-6 induced activation of STAT3 in prostate cancer cells.Role of Imaging in Prostate Cancer.Combined analysis of EGF+61G>A and TGFB1+869T>C functional polymorphisms in the time to androgen independence and prostate cancer susceptibility.Genome-Wide Methylation Patterns in Androgen-Independent Prostate Cancer Cells: A Comprehensive Analysis Combining MeDIP-Bisulfite, RNA, and microRNA Sequencing Data.Terfenadine induces anti-proliferative and apoptotic activities in human hormone-refractory prostate cancer through histamine receptor-independent Mcl-1 cleavage and Bak up-regulation.
P2860
Q24599547-60B878CD-4976-440B-869B-7747A92FE087Q24614665-C4B3B3B6-50B8-40F6-BE24-F0821CC5A28DQ24813698-4C731E35-5D5F-4E1A-9A13-DA7F9E85DEB5Q28389404-865250C7-25BE-42A8-B8D3-D8CBA6A204E5Q30438487-137984A0-7894-417F-9043-D37595804EE3Q35855104-E3A2911B-EFBA-4B73-9706-0BE0FA736F9EQ36276350-7E8494A9-96FB-443D-B4BA-5DDF3129DD6FQ40462635-02288D04-F902-4537-88C8-B7B990E4A7A8Q42559636-6890BCB4-4D55-453C-A0F0-50F3528E4263Q47674851-6DB089BC-05DB-4348-9EE9-55435A665D65Q49181813-0A901BF4-5BDF-4B93-B407-8A7A6547CE67Q53089642-E67FB0FA-3785-4E27-97BE-757DE9933DCD
P2860
Hormone-refractory prostate cancer: a multi-step and multi-event process.
description
2001 nî lūn-bûn
@nan
2001 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Hormone-refractory prostate cancer: a multi-step and multi-event process.
@ast
Hormone-refractory prostate cancer: a multi-step and multi-event process.
@en
type
label
Hormone-refractory prostate cancer: a multi-step and multi-event process.
@ast
Hormone-refractory prostate cancer: a multi-step and multi-event process.
@en
prefLabel
Hormone-refractory prostate cancer: a multi-step and multi-event process.
@ast
Hormone-refractory prostate cancer: a multi-step and multi-event process.
@en
P2093
P356
P1476
Hormone-refractory prostate cancer: a multi-step and multi-event process.
@en
P2093
A De La Taille
F Vacherot
S Gil Diez De Medina
P2888
P304
P356
10.1038/SJ.PCAN.4500534
P577
2001-01-01T00:00:00Z